Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) just unveiled an announcement.
Adherium Limited reported a loss of $12.68 million for the year ended June 30, 2025, an increase from the previous year’s loss. The company’s revenue slightly decreased to $817,237, while research and development expenses dropped as it shifted focus from clinical trials to commercialization. Sales and marketing costs rose significantly due to expansion in the US market. Despite ending the year with reduced cash reserves, Adherium successfully raised $4.492 million through an entitlement offer, exceeding its initial target.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on digital health technologies. The company specializes in developing and commercializing devices and software platforms aimed at enhancing medication adherence and patient outcomes, with a significant market focus on the United States.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.32M
See more data about ADR stock on TipRanks’ Stock Analysis page.